Molecular cytogenetic study of the NF2 gene deletion in meningioma in sudanese patients

Balkan Journal of Medical Genetics

Volumn 16, Issue 2, 2013, Pages 29-32

  AbdElmontalab Farah, Y ^a   Fadl Elmula, I ^b   Abushama, H M ^a   Kreskowski, K ^c   Liehr, T ^c  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Banding cytogenetics; Interphase fluorescence in situ hybridization (I FISH); Meningioma; NF2 Gene; Sudan; Tumor suppressor gene

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CHROMOSOME 22; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; INTERPHASE; KARYOTYPING; MALE; MENINGIOMA; SUDAN; TUMOR SUPPRESSOR GENE;

EID: 84903638855     PISSN: None     EISSN: 13110160     Source Type: Journal    
DOI: 10.2478/bjmg-2013-0028     Document Type: Article

References (13)

1. Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet. 2001; 93(3-4): 207-220. (Pubitemid 32799806)
2. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010; 99(3): 307-314.
3. Zankl H, Zang KD. Correlations between clinical and cytogenetical data in 180 meningiomas. Cancer Genet Cytogenet. 1980; 1(1): 351-356. (Pubitemid 10053302)
4. Louis DN, Ramesh V, Gusella JF. Neuropathol-ogy and molecular genetics of neurofbromato-sis 2 and related tumors. Brain Pathol. 1995; 5(2): 163-172.
5. Capodano AM. Nervous system: meningioma. Atlas Genet Cytogenet Oncol Haematol. July 2000 (http://Atlas GeneticsOncology.org/Tu-mors/ meningiomasID5014. html).
6. Verma RS, Babu A. Human Chromosomes: Principles and Techniques: A Manual of Basic Techniques. New York: McGraw-Hill Professional, 1995.
7. Liehr T. Fluorescence In Situ Hybridization (FISH) Application Guide. Berlin: Springer, 2009.
8. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic fndings. J Neuro-surg. 2004; 101(2): 210-218. (Pubitemid 38970995)
9. Espinosa AB, Tabernero MD, Maíllo A, Say-agués JM, Ciudad J, Merino M, et al. The cytoge-netic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res. 2006; 12(3 Pt 1): 772-780. (Pubitemid 43259857)
10. Griffn CA, Hruban RH, Long PP, Miller N, Volz P, Carson B, et al. Chromosome abnormalities in meningeal neoplasms: do they correlate with histology? Cancer Genet Cytogenet. 1994; 78(1): 46-52. (Pubitemid 24378605)
11. Lekanne Deprez RH, Riegman PH, van Drunen E, Warringa UL, Groen NA, Stefanko SZ, et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuro-pathol Exp Neurol. 1995; 54(2): 224-235.
12. Sondak VK, Swetter SM, Berwick MA. Gender disparities in patients with melanoma: breaking the glass ceiling. J Clin Oncol. 2012; 30(18): 2177-2178.
13. Shen Y, Nunes F, Stemmer-Rachamimov A, James M, Mohapatra G, Plotkin S, et al. Ge-nomic profling distinguishes familial multiple and sporadic multiple meningiomas. BMC Med Genomics. 2009; 2: 42